查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1291627

胰腺癌治療和診斷市場2023-2028年按類型（診斷、治療）、應用（醫院、診所和其他）和地區分類

Pancreatic Cancer Therapeutics and Diagnostics Market by Type (Diagnostics, Treatment), Application (Hospitals, Clinics, and Others), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

市場概述：

全球胰腺癌治療和診斷市場規模在2022年達到39.6億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到60.8億美元，在2023-2028年期間呈現7.46%的成長率（CAGR）。蓬勃發展的醫療保健行業、胰腺癌發病率的上升以及對殺死胰腺癌細胞的化療需求的升級代表了推動市場的一些關鍵因素。

胰腺癌治療方法和診斷方法是用於診斷胰腺癌和提供治療的醫療程序。這些治療方法和診斷方法包括超音波、電腦斷層掃描（CT）、磁共振成像（MRI）和正電子發射斷層掃描（PET）。它們依靠內視鏡超聲（EUS），使用超聲設備從腹部內部產生胰腺的圖像。它們有助於監測由於胰腺內細胞不受控制的生長而促使的腫瘤位置。他們協助進行活體組織切片，取出一小塊組織樣本，在顯微鏡下進行檢查。他們還協助進行實驗室檢查，如全血細胞計數（CBC）、膽道梗阻的肝酶測試，以及空腹血糖和糖化血紅蛋白（HbA1C）測試。因此，胰腺癌治療方法和診斷方法在全球的醫院和專科中心都有應用。

胰腺癌治療和診斷的市場趨勢：

目前，由於老年人口的增加和大眾的過度吸煙習慣，胰腺癌的發病率不斷上升，這是支持市場成長的關鍵因素之一。除此之外，世界各地的分子生物學、藥物和診斷技術的發展也在增加。這一點，加上繁榮的醫療保健行業，目前正在推動市場的成長。此外，對通過阻止胰腺癌細胞生長和分裂來殺死它們的化療需求不斷升級，也對市場產生了積極影響。此外，一些國家的管理機構正在廣泛投資於胰腺癌臨床試驗測試和脫氧核糖核酸（DNA）修復抑製劑與化療相結合。他們還專注於通過批准臨床階段的藥物來加強胰腺癌治療和診斷的成長。除此之外，在該行業經營的主要參與者正在推出一種促進抗腫瘤免疫反應的人源化單克隆抗體，用於治療食管和胃食管交界處和胰腺癌。他們還在開發和推出基於試劑盒的測試，通過確定BRCA1和BRCA2變體和評估基因組不穩定性來檢測胰腺癌，預計這將在未來幾年促進市場的成長。

本報告中回答的關鍵問題：

  • 迄今為止，全球胰腺癌治療和診斷市場的表現如何，未來幾年將如何表現？
  • 全球胰腺癌治療和診斷市場的驅動因素、限制因素和機會是什麼？
  • 主要的區域市場是什麼？
  • 哪些國家代表了最具吸引力的胰腺癌治療和診斷市場？
  • 基於類型的市場細分是什麼？
  • 胰腺癌治療和診斷市場中最有吸引力的類型是什麼？
  • 基於應用的市場細分是什麼？
  • 胰腺癌治療和診斷市場中最有吸引力的應用是哪個？
  • 全球胰腺癌治療和診斷市場的競爭結構是什麼？
  • 誰是全球胰腺癌治療和診斷市場的主要參與者/公司？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球胰腺癌治療和診斷市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按類型分類的市場

  • 診斷學
    • 市場趨勢
    • 關鍵領域
      • 影像學
      • 生物檢查
      • 內視鏡超聲
      • 其他領域
    • 市場預測
  • 治療
    • 市場趨勢
    • 關鍵領域
      • 靶向治療
      • 化療
      • 手術治療
      • 其他療法
    • 市場預測

第七章：按應用分類的市場

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第九章：驅動因素、限制因素和機會

  • 概述
  • 驅動因素
  • 限制因素
  • 機會

第十章：價值鏈分析

第十一章：波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十二章：價格分析

第十三章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • AstraZeneca plc
    • F. Hoffmann-La Roche Ltd.
    • Immunovia AB
    • Novartis AG
    • Pfizer Inc.

請注意，這只代表部分公司的名單，完整的名單已在報告中提供。

Product Code: SR112023A7538

Market Overview:

The global pancreatic cancer therapeutics and diagnostics market size reached US$ 3.96 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.08 Billion by 2028, exhibiting a growth rate (CAGR) of 7.46% during 2023-2028. The burgeoning healthcare industry, rising prevalence of pancreatic cancer, and the escalating demand for chemotherapy to kill pancreatic cancer cells represent some of the key factors driving the market.

Pancreatic cancer therapeutics and diagnostics are medical procedures used to diagnose pancreatic cancer and provide treatment. These therapeutics and diagnostics comprise ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. They rely on an endoscopic ultrasound (EUS) that uses an ultrasound device to produce images of the pancreas from inside the abdomen. They help in monitoring the location of the tumor due to an uncontrollable growth of cells in the pancreas. They assist in performing a biopsy to remove a small sample of tissue for examination under a microscope. They also aid in laboratory investigations, such as a complete blood count (CBC), liver enzyme tests for biliary obstruction, and fasting glucose and glycated hemoglobin (HbA1C) tests. As a result, pancreatic cancer therapeutics and diagnostics find applications in hospitals and specialty centers across the globe.

Pancreatic Cancer Therapeutics and Diagnostics Market Trends:

At present, the rising prevalence of pancreatic cancer due to the increasing geriatric population and excessive smoking habits among the masses represents one of the key factors supporting the growth of the market. Besides this, there is an increase in the development of molecular biology, drugs, and diagnostic technology around the world. This, along with the thriving healthcare industry, is currently propelling the growth of the market. In addition, the escalating demand for chemotherapy to kill pancreatic cancer cells by preventing them from growing and dividing is positively influencing the market. Moreover, governing agencies of several countries are extensively investing in pancreatic cancer clinical trial testing and deoxyribonucleic acid (DNA) repair inhibitors combined with chemotherapy. They are also focusing on enhancing the growth of pancreatic cancer therapeutics and diagnostics by approving drugs in the clinical phase. Apart from this, key players operating in the industry are introducing a humanized monoclonal antibody that promotes the anti-tumor immune response for treating esophageal and gastroesophageal junction and pancreatic cancer. They are also developing and introducing kit-based testing to detect pancreatic cancer by determining BRCA1 and BRCA2 variants and assessing genomic instability, which is projected to contribute to the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pancreatic cancer therapeutics and diagnostics market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type and application.

Type Insights:

  • Diagnostics
    • Imaging
    • Biopsy
    • Endoscopic Ultrasound
    • Others
  • Treatment
    • Targeted Therapies
    • Chemotherapy
    • Surgery
    • Others

The report has provided a detailed breakup and analysis of the pancreatic cancer therapeutics and diagnostics market based on the type. This includes diagnostics (imaging, biopsy, endoscopic ultrasound, and others) and treatment (targeted therapies, chemotherapy, surgery, and others). According to the report, treatment accounted for the largest market share.

Application Insights:

  • Hospitals
  • Clinics
  • Others

A detailed breakup and analysis of the pancreatic cancer therapeutics and diagnostics market based on application has also been provided in the report. This includes hospitals, clinics, and others. According to the report, hospitals represented the leading segment.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for pancreatic cancer therapeutics and diagnostics. Some of the factors driving the North America pancreatic cancer therapeutics and diagnostics market included advancements in diagnostic technologies, emerging therapies and treatment options, increasing healthcare expenditure, and government initiatives and funding.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global pancreatic cancer therapeutics and diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies include AstraZeneca plc, F. Hoffmann-La Roche Ltd., Immunovia AB, Novartis AG, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global pancreatic cancer therapeutics and diagnostics market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global pancreatic cancer therapeutics and diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive pancreatic cancer therapeutics and diagnostics markets?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the pancreatic cancer therapeutics and diagnostics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the pancreatic cancer therapeutics and diagnostics market?
  • What is the competitive structure of the global pancreatic cancer therapeutics and diagnostics market?
  • Who are the key players/companies in the global pancreatic cancer therapeutics and diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pancreatic Cancer Therapeutics and Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Imaging
      • 6.1.2.2 Biopsy
      • 6.1.2.3 Endoscopic Ultrasound
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Treatment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Targeted Therapies
      • 6.2.2.2 Chemotherapy
      • 6.2.2.3 Surgery
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AstraZeneca plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 F. Hoffmann-La Roche Ltd.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Immunovia AB
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Novartis AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Pfizer Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: North America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: North America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: United States: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: United States: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: China: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: China: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: India: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: India: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: France: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: France: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 65: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 67: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Value Chain Analysis
  • Figure 68: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Competitive Structure
  • Table 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Players